BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.430
+0.060 (4.38%)
At close: Dec 8, 2025, 4:00 PM EST
1.410
-0.020 (-1.40%)
After-hours: Dec 8, 2025, 6:24 PM EST
BioCardia Market Cap
BioCardia has a market cap or net worth of $15.18 million as of December 8, 2025. Its market cap has increased by 66.36% in one year.
Market Cap
15.18M
Enterprise Value
10.53M
1-Year Change
66.36%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $15.18M, a decrease of -47.80%. That is a compound annual growth rate of -6.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 8, 2025 | 15.18M | 51.86% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | 49.20M | 95.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |